Nicolae S. is a skilled scientist with extensive experience in the pharmaceutical and academic sectors. Currently serving as Lead Scientist at Nxera Pharma since June 2016, Nicolae S. previously held the position of Senior Scientist within the same company. Prior experience includes a role as Postdoctoral Research Associate at the University of Oxford from March 2014 to June 2016 and a brief tenure as Research Assistant at The Structural Genomics Consortium (SGC) in early 2014. Nicolae S. holds a Doctor of Philosophy (PhD) in Structural Biology from the University of Oxford, earned between 2009 and 2013, and a Bachelor of Science (BS) in Biochemistry from Jacobs University Bremen, completed from 2006 to 2009.
This person is not in any teams
This person is not in any offices
Nxera Pharma
Nxera Pharma (formerly Sosei Heptares) is a technology powered biopharma company, in pursuit of new specialty medicines to improve the lives of patients with unmet needs in Japan and globally. In addition to several products being commercialized in Japan, we are advancing an extensive pipeline of over 30 active programs from discovery through to late clinical stage internally and in partnership with leading pharma and biotech companies. This pipeline is focused on addressing major unmet needs in some of the fastest-growing areas of medicine across neurology, GI and immunology, metabolic disorders and rare diseases, and leverages the power of our unique and industry leading GPCR-targeted structure-based drug discovery “NxWave” platform to provide a sustainable source of best- or first-in-class candidates. Nxera employs over 350 talented people at key locations in Tokyo and Osaka (Japan), London and Cambridge (UK), Basel (Switzerland) and Seoul (South Korea) and is listed on the Tokyo Stock Exchange (ticker: 4565).